EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number - PubMed (original) (raw)

EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number

M A Kim et al. Histopathology. 2008 May.

Abstract

Aims: Epidermal growth factor receptor (EGFR) expression has been observed in a variety of solid tumours with the potential of new targeted therapeutic agents. The aim was to evaluate the EGFR status of gastric carcinoma (GC) using immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).

Methods and results: The EGFR status was evaluated in GC tissues from 511 patients using IHC and FISH. In addition, the clinicopathological characteristics were examined and the results were compared with the EGFR status. One hundred and forty cases (27.4%) showed EGFR overexpression by IHC. EGFR overexpression was associated with older age (P = 0.001), moderately or poorly differentiated histology (P = 0.001) and higher stage disease (P = 0.046). Sixteen cases (3.1%) showed high polysomy and 12 cases (2.3%) had gene amplification by FISH. The correlation between IHC and FISH results was statistically significant (P < 0.001). The patients with GC who had EGFR overexpression had an unfavourable prognosis and multivariate analysis showed that EGFR overexpression was a possible independent unfavourable prognostic factor.

Conclusions: EGFR overexpression was observed in a subset of cases with GC and was associated with an unfavourable prognosis. It will be important to evaluate EGFR status to interpret future clinical trials properly using EGFR targeted agents.

PubMed Disclaimer

Similar articles

• Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
  Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, Jarrett C, Carter J, Murphy BA, Netterville J, Burkey BB, Sinard R, Cmelak A, Levy S, Yarbrough WG, Slebos RJ, Hirsch FR. Chung CH, et al. J Clin Oncol. 2006 Sep 1;24(25):4170-6. doi: 10.1200/JCO.2006.07.2587. J Clin Oncol. 2006. PMID: 16943533
• Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
  Sasaki H, Shimizu S, Okuda K, Kawano O, Yukiue H, Yano M, Fujii Y. Sasaki H, et al. Lung Cancer. 2009 Jun;64(3):295-300. doi: 10.1016/j.lungcan.2008.10.005. Epub 2008 Dec 5. Lung Cancer. 2009. PMID: 19058870
• Comparison of FISH, PCR, and immunohistochemistry in assessing EGFR status in lung adenocarcinoma and correlation with clinicopathologic features.
  El-Zammar OA, Zhang S, Katzenstein AL. El-Zammar OA, et al. Diagn Mol Pathol. 2009 Sep;18(3):133-7. doi: 10.1097/PDM.0b013e3181857ea9. Diagn Mol Pathol. 2009. PMID: 19704257
• Automated analysis of FISH and immunohistochemistry images: a review.
  Theodosiou Z, Kasampalidis IN, Livanos G, Zervakis M, Pitas I, Lyroudia K. Theodosiou Z, et al. Cytometry A. 2007 Jul;71(7):439-50. doi: 10.1002/cyto.a.20409. Cytometry A. 2007. PMID: 17559119 Review.
• Well-differentiated gastric tumors/carcinomas.
  Ruszniewski P, Delle Fave G, Cadiot G, Komminoth P, Chung D, Kos-Kudla B, Kianmanesh R, Hochhauser D, Arnold R, Ahlman H, Pauwels S, Kwekkeboom DJ, Rindi G; Frascati Consensus Conference; European neuroendocrine Tumor Society. Ruszniewski P, et al. Neuroendocrinology. 2006;84(3):158-64. doi: 10.1159/000098007. Epub 2007 Feb 20. Neuroendocrinology. 2006. PMID: 17312375 No abstract available.

Cited by

• The Role of ctDNA in Gastric Cancer.
  Mencel J, Slater S, Cartwright E, Starling N. Mencel J, et al. Cancers (Basel). 2022 Oct 18;14(20):5105. doi: 10.3390/cancers14205105. Cancers (Basel). 2022. PMID: 36291888 Free PMC article. Review.
• Molecular-targeted first-line therapy for advanced gastric cancer.
  Song H, Zhu J, Lu D. Song H, et al. Cochrane Database Syst Rev. 2016 Jul 19;7(7):CD011461. doi: 10.1002/14651858.CD011461.pub2. Cochrane Database Syst Rev. 2016. PMID: 27432490 Free PMC article. Review.
• Recent Developments of Systemic Chemotherapy for Gastric Cancer.
  Arai H, Nakajima TE. Arai H, et al. Cancers (Basel). 2020 Apr 28;12(5):1100. doi: 10.3390/cancers12051100. Cancers (Basel). 2020. PMID: 32354119 Free PMC article. Review.
• Recent advances in understanding Cushing disease: resistance to glucocorticoid negative feedback and somatic USP8 mutations.
  Daniel E, Newell-Price J. Daniel E, et al. F1000Res. 2017 May 2;6:613. doi: 10.12688/f1000research.10968.1. eCollection 2017. F1000Res. 2017. PMID: 28529722 Free PMC article. Review.
• p85α promotes nucleolin transcription and subsequently enhances EGFR mRNA stability and EGF-induced malignant cellular transformation.
  Xie Q, Guo X, Gu J, Zhang L, Jin H, Huang H, Li J, Huang C. Xie Q, et al. Oncotarget. 2016 Mar 29;7(13):16636-49. doi: 10.18632/oncotarget.7674. Oncotarget. 2016. PMID: 26918608 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • GlyGen glycoinformatics resource

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal